title: Maximizing phenotype constraint and extracellular matrix production in primary human chondrocytes using arginine-glycine-aspartate concentration gradient hydrogels.
abstract: New systematic approaches are necessary to determine and optimize the chemical and mechanical scaffold properties for hyaline cartilage generation using the limited cell numbers obtained from primary human sources. Peptide functionalized hydrogels possessing continuous variations in physico-chemical properties are an efficient three-dimensional platform for studying several properties simultaneously. Herein, we describe a polyethylene glycol dimethacrylate (PEGDM) hydrogel system possessing a gradient of arginine-glycine-aspartic acid peptide (RGD) concentrations from 0mM to 10mM. The system is used to correlate primary human osteoarthritic chondrocyte proliferation, phenotype maintenance and extracellular matrix (ECM) production to the gradient hydrogel properties. Cell number and chondrogenic phenotype (CD14:CD90 ratios) were found to decline in regions with higher RGD concentrations, while regions with lower RGD concentrations maintained cell number and phenotype. Over three weeks of culture, hydrogel regions containing lower RGD concentrations experience an increase in ECM content compared to regions with higher RGD concentrations. Variations in actin amounts and vinculin organization were observed within the RGD concentration gradients that contribute to the differences in chondrogenic phenotype maintenance and ECM expression.
authors.affiliation: Department of Polymer Science, The University of Akron, Akron, OH 44308, USA.
authors.forename: Laura A
authors.initials: LA
authors.lastname: Smith Callahan
authors.forename: Erin P
authors.initials: EP
authors.lastname: Childers
authors.forename: Sharon L
authors.initials: SL
authors.lastname: Bernard
authors.forename: Scott D
authors.initials: SD
authors.lastname: Weiner
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Becker
mesh_terms: D002478:Cells, Cultured; D019902:Chondrocytes / Q000145:classification* / Q000187:drug effects / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005109:Extracellular Matrix / Q000378:metabolism*; D006801:Humans; D020100:Hydrogels / Q000737:chemistry*; D008422:Materials Testing; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D020100:Hydrogels; D009842:Oligopeptides; C047981:arginyl-glycyl-aspartic acid